Biomea Fusion
BMEA | NASDAQ
$0.52
-$0.06 (-10.68%)
At close: Nov 16, 2026, 4:00 PM ET
$0.55
+$0.03 (+5.77%)
After-hours:
Nov 16, 2026, 6:16 PM ET
-10.68%
(1D)No price chart data available for 1D timeframe.
Rating
37
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #610/1021 (Top 60%)
Key Statistics
Market Data
Market Cap $37.8M
1D Range
0.52 0.58
52W Range
0.52 2.21
Valuation (TTM)
PE -1.62
PB 4.98
EV/EBITDA -0.54
Valuation (NTM)
Forward PE N/A
Forward PEG 0.03
Price Target $19.00
Cash Flow
FCF Yield -114.6%
SBC Adj. FCF Yield -127.3%
SBC Impact -11.1%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y 82.4% |
20.8%
FCF 3Y | 5Y 42.9% |
5.2%
Returns
ROA -79.4%
ROE -131.3%
ROIC -317.2%
Financial Health
Net Cash
$26.4M
Current Ratio 2.17
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Biomea Fusion, Inc., a clinical-stage diabetes and obesity medicines company, focuses on the discovery and development of oral drugs to treat patients with diabetes and obesity. It’s lead clinical pro...
Sector Healthcare
Industry Biotechnology
Employees 37
IPO Date Apr 16, 2021
Website biomeafusion.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 10, 2026
EPS
-$0.09
Beat +56.57%
YoY:
+66.67% REV
$92K
Beat 0.00%
Next Earnings
Mar 23, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
4
Consensus
Buy
Price Target
$19.00
Upside
+3553.85%
Buy (4)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove BMEA